SUPPLEMENT

Q2 2020 — Condensed Consolidated Statement of Earnings

Q2 2020PDF · 2 pages30 KB
Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	18,336	$ 	100.0 	20,562	$ 	100.0 	(10.8)
Cost of products sold 	6,579 	35.9 	6,940 	33.8 	(5.2)
Gross Profit 	11,757 	64.1 	13,622 	66.2 	(13.7)
Selling, marketing and administrative expenses 	4,993 	27.2 	5,546 	27.0 	(10.0)
Research and development expense 	2,707 	14.8 	2,666 	13.0 	1.5
In-process research and development 	6 	0.0 	- 	-
Interest (income) expense, net 	26 	0.2 	(5) 	0.0
Other (income) expense, net 	24 	0.1 	(1,683) 	(8.2)
Restructuring 	61 	0.3 	57 	0.2
Earnings before provision for taxes on income 	3,940 	21.5 	7,041 	34.2 	(44.0)
Provision for taxes on income 	314 	1.7 	1,434 	6.9 	(78.1)
Net earnings 	3,626	$ 	19.8 	5,607	$ 	27.3 	(35.3)
Net earnings per share (Diluted) 	1.36	$ 	2.08	$ 	(34.6)
Average shares outstanding (Diluted) 	2,665.5 	2,691.7
Effective tax rate 	8.0 % 	20.4 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	5,337	$ 	29.1 	8,614	$ 	41.9 	(38.0)
Net earnings 	4,446	$ 	24.2 	6,950	$ 	33.8 	(36.0)
Net earnings per share (Diluted) 	1.67	$ 	2.58	$ 	(35.3)
Effective tax rate 	16.7 % 	19.3 %
(1) See Reconciliation of Non-GAAP Financial Measures.
SECOND QUARTER
2020 	2019

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited; in Millions Except Per Share Figures)
Percent
Percent 	Percent 	Increase
Amount 	to Sales 	Amount 	to Sales 	(Decrease)
Sales to customers 	39,027	$ 	100.0 	40,583	$ 	100.0 	(3.8)
Cost of products sold 	13,641 	35.0 	13,555 	33.4 	0.6
Gross Profit 	25,386 	65.0 	27,028 	66.6 	(6.1)
Selling, marketing and administrative expenses 	10,196 	26.1 	10,765 	26.5 	(5.3)
Research and development expense 	5,287 	13.5 	5,524 	13.6 	(4.3)
In-process research and development 	6 	0.0 	890 	2.2
Interest (income) expense, net 	(16) 	0.0 	(2) 	0.0
Other (income) expense, net 	(655) 	(1.7) 	(1,705) 	(4.2)
Restructuring 	119 	0.3 	93 	0.3
Earnings before provision for taxes on income 	10,449 	26.8 	11,463 	28.2 	(8.8)
Provision for taxes on income 	1,027 	2.7 	2,107 	5.1 	(51.3)
Net earnings 	9,422	$ 	24.1 	9,356	$ 	23.1 	0.7
Net earnings per share (Diluted) 	3.53	$ 	3.47	$ 	1.7
Average shares outstanding (Diluted) 	2,671.0 	2,697.0
Effective tax rate 	9.8 % 	18.4 %
Adjusted earnings before provision for taxes and net earnings (1)
Earnings before provision for taxes on income 	12,581	$ 	32.2 	15,481	$ 	38.1 	(18.7)
Net earnings 	10,600	$ 	27.2 	12,611	$ 	31.1 	(15.9)
Net earnings per share (Diluted) 	3.97	$ 	4.68	$ 	(15.2)
Effective tax rate 	15.7 % 	18.5 %
(1) See Reconciliation of Non-GAAP Financial Measures.
SIX MONTHS
2020 	2019

-- 2 of 2 --